Home › Funds › WEYBOSSET RESEARCH & MANAGEMENT LLC › BHVN

WEYBOSSET RESEARCH & MANAGEMENT LLC position in BHVN

BIOHAVEN LTD · Health Care

WEYBOSSET RESEARCH & MANAGEMENT LLC reported holding 20,000 shares of BHVN (BIOHAVEN LTD) in its Q3 2026 13F filing — a position valued at US$267K, representing 0.08% of its reported portfolio and ranking #31 among its reported holdings. WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)20.00K sh
Reported value held$267.00K
Portfolio Weight0.08%
First reportedQ3 2023
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How WEYBOSSET RESEARCH & MANAGEMENT LLC's BHVN position evolved

WEYBOSSET RESEARCH & MANAGEMENT LLC first disclosed a stake in BHVN in Q3 2023 at 12,140 shares (US$316K). The position peaked in Q1 2024 at 13,640 shares, worth US$5.1M. Across 13 filings, WEYBOSSET RESEARCH & MANAGEMENT LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 20,000 shares valued at US$267K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.14K $316.00K New
Q4 2023 13.64K $583.79K Add
Q1 2024 13.64K $5.08M Hold
Q2 2024 11.01K $382.00K Reduce
Q3 2024 11.01K $550.00K Hold
Q4 2024 13.64K $510.00K Add
Q1 2025 16.88K $405.80K Add
Q2 2025 19.28K $272.04K Add
Q3 2025 22.94K $344.33K Add
Q4 2025 22.99K $259.56K Hold
Q1 2026 22.99K $194.50K Hold
Q2 2026 20.00K $297.60K Reduce
Q3 2026 20.00K $267.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has WEYBOSSET RESEARCH & MANAGEMENT LLC held BHVN?

WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WEYBOSSET RESEARCH & MANAGEMENT LLC's current position in BHVN?

As of Q3 2026, WEYBOSSET RESEARCH & MANAGEMENT LLC holds 20.00K shares of BHVN (BIOHAVEN LTD), valued at $267.00K, representing 0.08% of its reported portfolio and ranking #31.

Has WEYBOSSET RESEARCH & MANAGEMENT LLC been buying or selling BHVN?

In the latest 13F filing (Q3 2026), WEYBOSSET RESEARCH & MANAGEMENT LLC held unchanged its position in BHVN. The position peaked in Q1 2024 at 13.64K shares.

Which other funds hold BHVN?

Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.